Saturday, April 26, 2008

The Face Betrays Deceiver's True Emotions

The researchers were able to discern rare “microexpressions,” flashes of true emotion that show briefly, from one-fifth to one-25th of a second, on the faces of participants when instructed to deceive.

read more | digg story

Friday, April 25, 2008

Scientists Have Found Real Proof that Astrology is Rubbish

Scientists have found astrology to be rubbish. Its central claim - that our human characteristics are moulded by the influence of the Sun, Moon and planets at the time of our birth - appears to have been debunked once and for all and beyond doubt by the most thorough scientific study ever made into it.

read more | digg story

Thursday, April 17, 2008

12 Tips to Improve the Quality of Your Free Time

Are you happier at your job, or during your free time? Unless you’ve followed the research of Mihaly Csikszentmihalyi you would probably be surprised at the actual answer. He conducted studies which recorded peoples current levels of happiness at random points both during work and off-hours.

read more | digg story

WARNING: Vitamins may increase Risk of Death

Supplements taken by millions may raise risk of premature death, claims new scientific review.

read more | digg story

Tuesday, April 15, 2008

Brain Scanners Can See Your Decisions Before You Make Them

You may think you decided to read this story -- but in fact, your brain made the decision long before you knew about it.

read more | digg story

Sunday, April 13, 2008

How much would you pay for a memory chip in your brian?

How much would you pay to have a small memory chip implanted in your brain if that chip would double the capacity of your short-term memory? Or guarantee that you would never again forget a face or a name?

read more | digg story

New Drug Treatment Could Cure Alzheimer's Disease in Minutes

Doctors are calling for a clinical trial of an experimental drug treatment that it is claimed can reverse the symptoms of Alzheimer's disease "in minutes". U.S. researchers say the treatment allowed an 82-year- old sufferer to recognise his wife for the first time in years.

read more | digg story

Tuesday, April 8, 2008

NYU professor discovers a new biological clock

This clock, or biological rhythm, controls many metabolic functions and is based on the circadian rhythm, which is a roughly 24-hour cycle that is important in determining sleeping and feeding patterns, cell regeneration, and other biological processes in mammals.

read more | digg story

Sunday, April 6, 2008

9 Things to Stop Worrying about Right Now

From eggs raising cholesterol to cold weather giving you a cold, Health magazine busts the biggest health myths out there.

read more | digg story

Wednesday, April 2, 2008

Hormone Therapy Health Risks

Hormone Therapy Health Risks

A new study evaluated the health risks and benefits of estrogen and progestin therapy and found an increased risk of fatal and nonfatal illnesses (malignancies).

Researchers from the University of North Carolina, Chapel Hill, reported that the Women's Health Initiative (WHI) trial of estrogen plus progestin was stopped early, after a mean of 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits.

The study analyzed health outcomes three years (mean 2.4 years of follow-up) after the intervention was stopped.

The intervention phase was a double-blind, placebo-controlled, randomized trial of estrogen plus progestin (conjugated equine estrogens 0.625 milligrams daily plus medroxyprogesterone acetate 2.5 milligrams daily) in 16,608 women aged 50-79 years. The post-intervention phase commenced July 8, 2002 and included 15,730 women.

The primary end points were coronary heart disease and invasive breast cancer. A global index summarizing the balance of risks and benefits included the two primary end points plus stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip fracture and death due to other causes.

The study found that after the intervention, cardiovascular risk was comparable by initial randomized assignments: 1.97 percent (annualized rate) in the hormone therapy group (343 events) and 1.91 percent in the placebo group (323 events).

The researchers observed a greater risk of malignancies in the estrogen plus progestin group than in the placebo group (1.56 percent vs. 1.26 percent). More breast cancers were diagnosed in women who had been randomly assigned to receive hormone therapy vs. placebo (0.42 percent vs. 0.33 percent) with a modest trend toward a lower hazard ratio during the follow-up after the intervention.

All-cause mortality was somewhat higher in the estrogen plus progestin group than in the placebo group (1.20 percent vs. 1.06 percent).

The global index of risks and benefits was unchanged from randomization through March 31, 2005, indicating that the risks of estrogen plus progestin therapy exceed the benefits for chronic disease prevention, reported the researchers.

The increased cardiovascular risks in the women assigned to hormone therapy during the intervention period were not observed after the intervention.

The study authors concluded that a greater risk of fatal and nonfatal malignancies occurred after the intervention in the estrogen plus progestin group and the global risk index was 12 percent higher in women randomly assigned to receive conjugated equine estrogens plus medroxyprogesterone acetate compared with placebo.

Integrative therapies with good scientific evidence in the treatment of menopause include calcium, sage and soy.

Calcium is the nutrient consistently found to be the most important for attaining peak bone mass and preventing osteoporosis. Adequate vitamin D intake is required for optimal calcium absorption. Adequate calcium and vitamin D are deemed essential for the prevention of osteoporosis in general, including postmenopausal osteoporosis. There is a link between lower dietary intake of calcium and symptoms of premenstrual syndrome. Calcium supplementation has been suggested in various clinical trials to decrease overall symptoms associated with PMS, such as depressed mood, water retention and pain.

Sage (Salvia officinalis) may contain compounds with mild estrogenic activity. In theory, estrogenic compounds may decrease the symptoms of menopause. Sage has been tested against menopausal symptoms with promising results.

Soy (Glycine max) products containing isoflavones have been studied for the reduction of menopausal symptoms such as hot flashes. The scientific evidence is mixed in this area, with several human trials suggesting a reduced number of hot flashes and other menopausal symptoms, but more recent research reporting no benefits. Overall, the scientific evidence does suggest benefits, although better quality studies are needed in this area in order to form a firm conclusion.

Integrative therapies with fair negative evidence in the treatment of menopause include boron, evening primrose oil and wild yam.

Boron is a trace mineral found in soil, water and some foods. It has been proposed that boron affects estrogen levels in post-menopausal women. However, preliminary studies have found no changes in menopausal symptoms.

Available studies do not show evening primrose (Oenothera biennis) oil to be helpful with these potential complications of menopause. Small human studies do not report that evening primrose oil is helpful for the symptoms of PMS.

Despite popular belief, no natural progestins, estrogens or other reproductive hormones are found in wild yam. Its active ingredient, diosgenin, is not converted to hormones in the human body. Artificial progesterone has been added to some wild yam products. The belief that there are hormones in wild yam may be due to the historical fact that progesterone, androgens and cortisone were chemically manufactured from Mexican wild yam in the 1960s. From Natural Standard



A Unique View of Disease

Researchers have been working on ways to visualize molecular changes that take place inside the body, and a new method may offer some advantages over existing anatomical and molecular imaging technologies.

read more | digg story